Paper Details

  1. Home
  2. Paper Details

Felbamate add-on therapy for drug-resistant focal epilepsy.

Author: BresnahanRebecca, DongJianCheng, GengJinSong, Martin-McGillKirsty J, NiHengJian, ShiLi Li

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This updated Cochrane Review examines the use of felbamate, a second-generation antiepileptic drug, as add-on therapy for people with epilepsy whose seizures are resistant to standard antiepileptic drugs.
Paper Details　
Original Abstract of the Article :
This is an updated version of the Cochrane Review previously published in 2017.Epilepsy is a chronic and disabling neurological disorder, affecting approximately 1% of the population. Up to 30% of people with epilepsy have seizures that are resistant to currently available antiepileptic drugs and re...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699672/

データ提供：米国国立医学図書館（NLM）

Felbamate: A Potential Add-on Therapy for Drug-Resistant Epilepsy

Epilepsy, a chronic neurological disorder characterized by recurrent seizures, can significantly impact a person's life. For patients with drug-resistant epilepsy, finding effective treatment options is a constant challenge. This review explores the potential of felbamate, a second-generation antiepileptic drug, as an add-on therapy for individuals whose seizures remain uncontrolled despite conventional treatments.

Felbamate Offers Hope for Drug-Resistant Epilepsy

The review highlights felbamate's potential as an add-on therapy for individuals with drug-resistant epilepsy. While further research is needed to fully understand its efficacy and safety profile, it offers a potential avenue for improving seizure control in patients who have not responded well to other treatments. This review provides valuable information for clinicians seeking to optimize treatment strategies for individuals with drug-resistant epilepsy.

Finding the Right Path Through the Desert of Epilepsy

Imagine epilepsy as a desert storm, unpredictable and disruptive. For patients with drug-resistant epilepsy, finding the right treatment is like searching for a safe haven within the storm. Felbamate, like a well-placed oasis, could offer a respite from the tumultuous storm, providing relief and improving quality of life for those who have long struggled to manage their seizures. This research provides a glimmer of hope for individuals seeking effective treatment options.

Dr.Camel's Conclusion

This review sheds light on the potential of felbamate as an add-on therapy for individuals with drug-resistant epilepsy. While more research is needed to confirm its long-term efficacy and safety, it offers a promising avenue for improving seizure control in this challenging population. Remember, finding the right path through the desert of epilepsy requires careful consideration of various treatment options and close collaboration with healthcare professionals. With hope and perseverance, we can strive to mitigate the impact of this disorder and improve the lives of those affected.

Date :
  1. Date Completed 2019-09-24
  2. Date Revised 2022-08-04
Further Info :

Pubmed ID

31425617

DOI: Digital Object Identifier

PMC6699672

Related Literature

Article Analysis
・Effective treatment of epilepsy
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.